GALR1 and colorectal carcinoma: However, Stevenson et al (34) showed that GALR1/GAL silencing downregulates FLIPL and activates caspase-8-dependent apoptosis in CRC cells, and thus suggested that high GAL expression would promote high FLIP expression and result in a more aggressive phenotype and chemotherapy resistance.